Jennison Associates’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Jennison Associates's RGEN Position: Q1 2026 in Review
Jennison Associates reduced its Repligen (RGEN) stake by 1.9% in Q1 2026, selling an estimated $330K and leaving 121,239 shares worth $14.3M. The position accounts for 0.01% of the portfolio, ranked #355.
Jennison Associates first reported a position in RGEN in Q2 2017 and has held it in 21 quarters since. The position peaked at $37.5M in Q1 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Jennison Associates held 121,239 shares of Repligen worth $14.3M as of Q1 2026.
- Jennison Associates sold 2,361 Repligen shares in Q1 2026, an estimated $330K.
- Repligen made up 0.01% of Jennison Associates's portfolio in Q1 2026, its #355 holding.
- Jennison Associates first reported a position in Repligen in Q2 2017 and has held it in 21 quarters since.
- Jennison Associates's Repligen position peaked at $37.5M in Q1 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.